Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Diminished DEFA6 Expression in Paneth Cells Is Associated with Necrotizing Enterocolitis.

Markasz L, Wanders A, Szekely L, Lilja HE.

Gastroenterol Res Pract. 2018 Oct 21;2018:7345426. doi: 10.1155/2018/7345426. eCollection 2018.

2.

Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia.

Ge Z, Han Q, Gu Y, Ge Q, Ma J, Sloane J, Gao G, Payne KJ, Szekely L, Song C, Dovat S.

Oncogenesis. 2018 Nov 12;7(11):84. doi: 10.1038/s41389-018-0095-x.

3.

Pregnant intravenous drug user tricuspid valve infective endocarditis treated with a successful simultaneous valve replacement and Cesarean section.

Ahres A, Rubóczky G, Somogyi P, Kapin T, Apor A, Ludwig E, Székely L, Andrássy P.

Echocardiography. 2018 Sep;35(9):1452-1455. doi: 10.1111/echo.14122. Epub 2018 Aug 26.

PMID:
30145842
4.

Cellular-resolution 3D virtual histology of human coronary arteries using x-ray phase tomography.

Vågberg W, Persson J, Szekely L, Hertz HM.

Sci Rep. 2018 Jul 20;8(1):11014. doi: 10.1038/s41598-018-29344-3.

5.

[Perioperative use of levosimendan in cardiac surgery. Hungarian recommendation].

Szudi L, Székely L, Sápi E, Prodán Z, Szolnoky J, Csomós Á, Nyolczas N, Paulovich E, Németh E, Hartyánszky I, Zima E, Sax B, Bertalan A, Hejjel L, Bogáts G, Babik B, Gombocz K, Szerafin T, Koszta G, Molnár A.

Orv Hetil. 2018 Jun;159(22):870-877. doi: 10.1556/650.2018.31083. Hungarian.

PMID:
29806474
6.

Global dynamics of a mathematical model for the possible re-emergence of polio.

Dénes A, Székely L.

Math Biosci. 2017 Nov;293:64-74. doi: 10.1016/j.mbs.2017.08.010. Epub 2017 Aug 30.

PMID:
28859911
7.

Sensitivity of chronic lymphocytic leukemia cells to small targeted therapeutic molecules: An in vitro comparative study.

Sylvan SE, Skribek H, Norin S, Muhari O, Österborg A, Szekely L.

Exp Hematol. 2016 Jan;44(1):38-49.e1. doi: 10.1016/j.exphem.2015.08.009. Epub 2015 Aug 29.

PMID:
26325331
8.

Multimodality Imaging of Giant Right Coronary Aneurysm and Postsurgical Coronary Artery Inflammation.

Celeng C, Székely L, Tóth A, Dénes M, Csobay-Novák C, Bartykowszki A, Károlyi M, Vágó H, Szőke S, Coelho Filho OR, Andréka P, Merkely B, Maurovich-Horvat P.

Circulation. 2015 Jul 7;132(1):e1-5. doi: 10.1161/CIRCULATIONAHA.114.014021. No abstract available.

PMID:
26149430
9.

Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth.

Alexeyenko A, Alkasalias T, Pavlova T, Szekely L, Kashuba V, Rundqvist H, Wiklund P, Egevad L, Csermely P, Korcsmaros T, Guven H, Klein G.

J Exp Clin Cancer Res. 2015 Jun 18;34:62. doi: 10.1186/s13046-015-0178-x.

10.

Drug sensitivity profiling and molecular characteristics of cells from pleural effusions of patients with lung adenocarcinoma.

Ötvös R, Szulkin A, Hillerdal CO, Celep A, Yousef-Fadhel E, Skribek H, Hjerpe A, Székely L, Dobra K.

Genes Cancer. 2015 Mar;6(3-4):119-128.

11.

Inhibition of protein phosphatase-1 and -2A decreases the chemosensitivity of leukemic cells to chemotherapeutic drugs.

Dedinszki D, Kiss A, Márkász L, Márton A, Tóth E, Székely L, Erdődi F.

Cell Signal. 2015 Feb;27(2):363-72. doi: 10.1016/j.cellsig.2014.11.021. Epub 2014 Nov 27.

PMID:
25435424
12.

Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent.

Alkasalias T, Flaberg E, Kashuba V, Alexeyenko A, Pavlova T, Savchenko A, Szekely L, Klein G, Guven H.

Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17188-93. doi: 10.1073/pnas.1419554111. Epub 2014 Nov 17.

13.

Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions.

Szulkin A, Otvös R, Hillerdal CO, Celep A, Yousef-Fadhel E, Skribek H, Hjerpe A, Székely L, Dobra K.

BMC Cancer. 2014 Sep 24;14:709. doi: 10.1186/1471-2407-14-709.

14.

Dominating scale-free networks using generalized probabilistic methods.

Molnár F Jr, Derzsy N, Czabarka É, Székely L, Szymanski BK, Korniss G.

Sci Rep. 2014 Sep 9;4:6308. doi: 10.1038/srep06308.

15.

Decreased decorin expression in the tumor microenvironment.

Bozoky B, Savchenko A, Guven H, Ponten F, Klein G, Szekely L.

Cancer Med. 2014 Jun;3(3):485-91. doi: 10.1002/cam4.231. Epub 2014 Mar 17.

16.

Molecular typing of human herpesvirus 8 isolates from patients with Kaposi's sarcoma in Hungary.

Ötvös R, Juhasz A, Szalai E, Ujvari D, Ötvös K, Szabo K, Remenyik E, Szekely L, Gergely L, Konya J.

Anticancer Res. 2014 Feb;34(2):893-8.

PMID:
24511028
17.

Improved in vitro culture of Plasmodium falciparum permits establishment of clinical isolates with preserved multiplication, invasion and rosetting phenotypes.

Ribacke U, Moll K, Albrecht L, Ahmed Ismail H, Normark J, Flaberg E, Szekely L, Hultenby K, Persson KE, Egwang TG, Wahlgren M.

PLoS One. 2013 Jul 22;8(7):e69781. doi: 10.1371/journal.pone.0069781. Print 2013.

18.
19.

Novel signatures of cancer-associated fibroblasts.

Bozóky B, Savchenko A, Csermely P, Korcsmáros T, Dúl Z, Pontén F, Székely L, Klein G.

Int J Cancer. 2013 Jul 15;133(2):286-93. doi: 10.1002/ijc.28035. Epub 2013 Feb 12.

20.

Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.

Schennings T, Farnebo F, Szekely L, Flock JI.

APMIS. 2012 Oct;120(10):786-93. doi: 10.1111/j.1600-0463.2012.02907.x. Epub 2012 May 7.

PMID:
22958286
21.

Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan.

Cheng HH, Kuo CC, Yan JL, Chen HL, Lin WC, Wang KH, Tsai KK, Guvén H, Flaberg E, Szekely L, Klein G, Wu KK.

Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13231-6. doi: 10.1073/pnas.1209919109. Epub 2012 Jul 31.

22.

[Right ventricular outflow tract reconstruction in adolescents and adults after previous repair of congenital heart defects].

Hartyánszky I, Székely L, Szudi L, Mihályi S, Kádár K, Temesvári A, Bálint H, Szatmári A, Tóth A.

Orv Hetil. 2012 Aug 5;153(31):1219-24. doi: 10.1556/OH.2012.29428. Hungarian.

PMID:
22846490
23.

High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer.

Li J, Szekely L, Eriksson L, Heddson B, Sundbom A, Czene K, Hall P, Humphreys K.

Breast Cancer Res. 2012 Jul 30;14(4):R114. doi: 10.1186/bcr3238.

24.

Electron diffraction based analysis of phase fractions and texture in nanocrystalline thin films, part III: application examples.

Lábár JL, Adamik M, Barna BP, Czigány Z, Fogarassy Z, Horváth ZE, Geszti O, Misják F, Morgiel J, Radnóczi G, Sáfrán G, Székely L, Szüts T.

Microsc Microanal. 2012 Apr;18(2):406-20. doi: 10.1017/S1431927611012803.

PMID:
22436336
25.

Symbionts as major modulators of insect health: lactic acid bacteria and honeybees.

Vásquez A, Forsgren E, Fries I, Paxton RJ, Flaberg E, Szekely L, Olofsson TC.

PLoS One. 2012;7(3):e33188. doi: 10.1371/journal.pone.0033188. Epub 2012 Mar 12.

26.

The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth.

Flaberg E, Guven H, Savchenko A, Pavlova T, Kashuba V, Szekely L, Klein G.

Int J Cancer. 2012 Nov 15;131(10):2274-83. doi: 10.1002/ijc.27521. Epub 2012 Mar 29.

27.

Rho GTPases link cellular contractile force to the density and distribution of nanoscale adhesions.

Gad AK, Rönnlund D, Spaar A, Savchenko AA, Petranyi G, Blom H, Szekely L, Widengren J, Aspenström P.

FASEB J. 2012 Jun;26(6):2374-82. doi: 10.1096/fj.11-195800. Epub 2012 Feb 27.

PMID:
22371528
28.

Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines.

Otvös R, Skribek H, Kis LL, Gloghini A, Markasz L, Flaberg E, Eksborg S, Konya J, Gergely L, Carbone A, Szekely L.

BMC Cancer. 2011 Oct 12;11:441. doi: 10.1186/1471-2407-11-441.

29.

Hypothermia down-regulates the LPS-induced norepinephrine (NE) release in ischaemic human heart cells.

Szelényi M, László Z, Szabó Z, Kromplák Z, Tischler E, Lakatos M, Székely L.

Brain Res Bull. 2012 Jan 4;87(1):67-73. doi: 10.1016/j.brainresbull.2011.09.012. Epub 2011 Sep 24.

PMID:
21963948
30.

Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.

Li H, Lakshmikanth T, Garofalo C, Enge M, Spinnler C, Anichini A, Szekely L, Kärre K, Carbone E, Selivanova G.

Cell Cycle. 2011 Oct 1;10(19):3346-58. doi: 10.4161/cc.10.19.17630. Epub 2011 Oct 1.

PMID:
21941086
31.

The sum of the distances between the leaves of a tree and the 'semi-regular' property.

Székely LA, Wang H, Wu T.

Discrete Math. 2011 Jul 6;311(13):1197-1203.

32.

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin.

Skribek H, Otvos R, Flaberg E, Nagy N, Markasz L, Eksborg S, Masszi T, Kozma A, Adam E, Miseta A, Klein E, Szekely L.

Exp Hematol. 2010 Dec;38(12):1219-30. doi: 10.1016/j.exphem.2010.09.001. Epub 2010 Sep 15.

PMID:
20837094
33.

High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts.

Flaberg E, Markasz L, Petranyi G, Stuber G, Dicso F, Alchihabi N, Oláh È, Csízy I, Józsa T, Andrén O, Johansson JE, Andersson SO, Klein G, Szekely L.

Int J Cancer. 2011 Jun 15;128(12):2793-802. doi: 10.1002/ijc.25612. Epub 2010 Dec 29.

34.

Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53.

Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Szekely L, Bercovich B, Ciechanover A, Klein G.

Int J Cancer. 2011 Feb 15;128(4):817-25. doi: 10.1002/ijc.25414.

35.

Rescue of p53 function by small-molecule RITA in cervical carcinoma by blocking E6-mediated degradation.

Zhao CY, Szekely L, Bao W, Selivanova G.

Cancer Res. 2010 Apr 15;70(8):3372-81. doi: 10.1158/0008-5472.CAN-09-2787. Erratum in: Cancer Res. 2017 Jul 1;77(13):3719.

36.

The inverse problem for certain tree parameters.

Czabarka E, Székely L, Wagner S.

Discrete Appl Math. 2009 Aug 6;157(15):3314-3319.

37.

An improved bound on the Maximum Agreement Subtree problem.

Steel M, Székely LA.

Appl Math Lett. 2009 Nov 1;22(11):1778-1780.

38.

'The patient will see you now'.

Michalak J, Schreiner NJ, Tennis W, Szekely L, Hale M, Guastello S.

Am J Nurs. 2010 Jan;110(1):61-3. doi: 10.1097/01.NAJ.0000366060.37099.38. No abstract available.

PMID:
20032673
39.

MRPS18-2 protein immortalizes primary rat embryonic fibroblasts and endows them with stem cell-like properties.

Kashuba E, Pavan Yenamandra S, Darekar SD, Yurchenko M, Kashuba V, Klein G, Szekely L.

Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19866-71. doi: 10.1073/pnas.0911545106. Epub 2009 Nov 10.

40.

High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy.

Eriksson SE, Prast-Nielsen S, Flaberg E, Szekely L, Arnér ES.

Free Radic Biol Med. 2009 Dec 1;47(11):1661-71. doi: 10.1016/j.freeradbiomed.2009.09.016. Epub 2009 Sep 17.

PMID:
19766715
41.

Phylogenetic information complexity: is testing a tree easier than finding it?

Steel M, Székely L, Mossel E.

J Theor Biol. 2009 May 7;258(1):95-102. doi: 10.1016/j.jtbi.2009.01.007. Epub 2009 Jan 20.

PMID:
19490881
42.

Capillary gel electrophoresis of therapeutic oligonucleotides--analysis of single- and double-stranded forms.

Székely L, Kiessig S, Schwarz MA, Kálmán F.

Electrophoresis. 2009 May;30(9):1579-86. doi: 10.1002/elps.200800380.

PMID:
19425006
43.

PRIMA-1MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein.

Stuber G, Flaberg E, Petranyi G, Otvös R, Rökaeus N, Kashuba E, Wiman KG, Klein G, Szekely L.

Mol Cancer. 2009 Mar 26;8:23. doi: 10.1186/1476-4598-8-23.

44.

[The first percutaneous aortic valve implantation in Hungary].

Fontos G, Piróth Z, Szoke S, Tóth G, Vincze D, Szegedi M, Szüts K, Temesvári A, Hódi G, Székely L, Olev L, Andréka P.

Orv Hetil. 2009 Mar 1;150(9):387-96. doi: 10.1556/OH.2009.28563. Hungarian.

PMID:
19228567
45.

On the expectation and variance of the reversal distance.

Székely LA, Yang Y.

Acta Univ Sapientiae Matem. 2009 Jan 1;1(1):5-20.

46.
47.

NK cell-mediated lysis is essential to kill Epstein-Barr virus transformed lymphoblastoid B cells when using rituximab.

Markasz L, Vanherberghen B, Flaberg E, Otvös R, Stuber G, Gustafsson Jernberg A, Olah E, Skribek H, Szekely L.

Biomed Pharmacother. 2009 Jul;63(6):413-20. doi: 10.1016/j.biopha.2008.08.009. Epub 2008 Oct 1.

PMID:
18834693
48.

Extended Field Laser Confocal Microscopy (EFLCM): combining automated Gigapixel image capture with in silico virtual microscopy.

Flaberg E, Sabelström P, Strandh C, Szekely L.

BMC Med Imaging. 2008 Jul 16;8:13. doi: 10.1186/1471-2342-8-13.

49.

EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes.

Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Isaguliants M, Szekely L, Klein G.

Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5489-94. doi: 10.1073/pnas.0801053105. Epub 2008 Apr 7.

50.

Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes.

Markasz L, Skribek H, Uhlin M, Otvos R, Flaberg E, Eksborg S, Olah E, Stuber G, Szekely L.

J Immunother. 2008 Apr;31(3):283-93. doi: 10.1097/CJI.0b013e3181628b76.

PMID:
18317359

Supplemental Content

Loading ...
Support Center